Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mohammed Eslam MD, PhD

Mohammed Eslam MD, PhD

Associate Professor, Storr Liver Center, University of Sydney, Sydney, Australia

Professor Mohammed Eslam is an Associate Professor at Storr Liver Centre, Sydney University. He heads the fatty liver and genomics groups at Storr Liver Centre and the International Liver Genetics Consortium that led to the identification of genetic and epigenetic factors that impact hepatic steatosis, inflammation and fibrosis. He undertakes basic and clinical research on MAFLD, hepatitis C, liver cancer and hepatic fibrosis. He is on the Editorial Board of Hepatology, Liver International and JCTH. He has had >130 publications.


Prof. Eslam has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. MAFLD and NAFLD in the General Population